Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Vanillic acid is a naturally occurring phenolic compound classified as a dihydroxybenzoic acid derivative and the oxidized form of vanillin. It is widely found in plants (notably in the root of Angelica sinensis), foods (such as wine and vinegar), and natural oils (including argan oil and açaí oil). Vanillic acid serves primarily as a flavoring agent and food additive. Pharmacologically, it exhibits antioxidant and anti-inflammatory properties by inhibiting pro-inflammatory cytokines like TNF-α and IL-6 through suppression of NF-κB activity. It also modulates oxidative stress pathways via upregulation of Nrf2/HO-1 signaling. Experimental studies suggest neuroprotective effects relevant to neurodegenerative diseases such as Alzheimer's disease[1][5][8]. Vanillic acid is an intermediate in the bioconversion from ferulic acid to vanillin.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Vanillic acid.